Skip to search formSkip to main contentSkip to account menu

docarpamine

Known as: N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine, do carpamine 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

DopamineDopamine Agonists

Narrower (1)

TA-8704
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Treatment for ovarian hyperstimulation syndrome using an oral dopamine prodrug ,docarpamine
Dopamine treatment constitutes a major advance towards the management of severe ovarian hyperstimulation syndrome (OHSS) by… 
2000
2000
THE EFFECT OF DOCARPAMINE, A DOPAMINE PRO-DRUG, ON BLOOD PRESSURE AND CATECHOLAMINE LEVELS IN SPONTANEOUSLY HYPERTENSIVE RATS
We studied the effects of bolus intravenous injection of the dopamine prodrug, docarpamine (200 μg/kg), on mean arterial pressure… 
2000
2000
Effects of docarpamine on hemodynamics after open heart surgery in children.
Docarpamine is a dopamine prodrug which has been selected from a large number of dopamine derivatives in order to develop an… 
1999
1999
Oral Administration of the Dopamine Prodrug Docarpamine Shortens Need for Drip Infusion of Dopamine in Patients with Low Cardiac Output Syndrome After Cardiac Surgery
Background: Methods: Results: Conclusion: 
1999
1999
Effects of a new orally active dopamine prodrug, docarpamine, on refractory ascites: a pilot study
OBJECTIVE:Refractory ascites is a debilitating condition in patients with cirrhosis. Recently, docarpamine, an orally active… 
1996
1996
Plasma concentration and acute clinical effects of docarpamine, orally active dopamine prodrug, in infants
Currently, there are no data available on the optimal doses and efficacy of docarpamine in infants. In the present study, three… 
1995
1995
Metabolism of dopamine prodrug, docarpamine.
Docarpamine is a dopamine prodrug which has been selected from a large number of dopamine derivatives in order to develop an… 
1991
1991
Comparison of cardiorenal and emetic effects of dopamine prodrugs docarpamine (TA-870) and levodopa in dogs.
Positive inotropic and renal vasodilatory effects of a novel dopamine prodrug, docarpamine, [N-(N-acetyl-L-methionyl)-3,4-bis… 
1990
1990
Metabolism of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine after oral administration to rats and dogs.
The metabolism of an orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and of… 
Review
1990
Review
1990
Development of dopaminergic drugs for the chronic treatment of congestive heart failure.
1. The search of orally active dopaminergic drugs for the chronic treatment of congestive heart failure has followed two… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)